Package Leaflet: Information for the Patient
Tramadol Almus 50 mg Hard Capsules EFG
tramadol, hydrochloride
Read all of this leaflet carefully before you start taking this medicine, because it contains important information for you.
Contents of the pack
Tramadol - the active substance of this medicine - is an analgesic belonging to the group of opioids that acts on the central nervous system. It relieves pain by acting on specific nerve cells in the spinal cord and brain.
Tramadol Almus is used for the treatment of moderate to severe pain, in adults and adolescents over 12 years of age.
Do not takeTramadolAlmus
Warnings and precautions
Consult your doctor or pharmacist before starting to take Tramadol:
There is a weak risk that you may experience a serotonin syndrome that can occur after taking tramadol in combination with certain antidepressants or tramadol alone. Consult your doctor immediately if you experience any of the symptoms associated with this serious syndrome (see section 4 "Possible side effects").
If you are in any of the above situations, consult your doctor before starting to take this medicine.
Tolerance, dependence, and addiction
This medicine contains tramadol, which is an opioid medicine. Repeated use of opioids may make the drug less effective (the body gets used to it, which is known as pharmacological tolerance). Repeated use of Tramadol Almus may also lead to dependence, abuse, and addiction, which could lead to a potentially life-threatening overdose.
The risk of these side effects may be greater with a higher dose and longer use.
Dependence or addiction may cause a feeling of lack of control over the amount of medicine you need to use or how often you need to use it.
The risk of dependence or addiction varies from person to person.
The risk of becoming dependent on or addicted to Tramadol Almus may be greater if:
If you notice any of the following symptoms while taking Tramadol Almus, it could be a sign of dependence or addiction:
If you notice any of these signs, consult your doctor to determine the best treatment option for you, when it is appropriate to stop the medicine, and how to do it safely (see section 3, if you stop taking Tramadol Almus).
Respiratory disorders related to sleep
Tramadol Almus may cause sleep-related respiratory disorders such as central sleep apnea (shallow breathing or pauses in breathing during sleep) and sleep-related hypoxemia (low oxygen level in the blood).
The risk of experiencing central sleep apnea depends on the dose of opioids. Your doctor may consider reducing the total dose of opioids if you experience central sleep apnea.
Seizures have been reported in patients taking tramadol at the recommended dose. The risk may increase when the dose of tramadol exceeds the maximum recommended daily dose (400 mg).
Note that this medicine may cause physical and psychological dependence. When used for a prolonged period, its effect may decrease, requiring the use of higher doses (development of tolerance). In patients with a tendency to abuse medicines or those with drug dependence, treatment with Tramadol Almus should only be carried out for short periods and under strict medical control.
Also, inform your doctor if any of these problems occur during treatment with this medicine or if you have experienced them before.
Tramadol is transformed in the liver by an enzyme. Some people have a variation of this enzyme, and this can affect each person differently. In some people, sufficient pain relief may not be achieved, while others are more likely to experience serious side effects. If you notice any of the following side effects, you must stop taking this medicine and consult a doctor immediately: slow or shallow breathing, confusion, drowsiness, constricted pupils, general malaise, or vomiting, constipation, loss of appetite.
Tell your doctor if you experience any of the following symptoms while taking tramadol:
Extreme fatigue, loss of appetite, severe abdominal pain, nausea, vomiting, or low blood pressure. This may indicate that you have adrenal insufficiency (low cortisol levels). If you experience any of these symptoms, inform your doctor, who will decide whether you should take a hormonal supplement.
Taking Tramadol Almus with other medicines
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
Concomitant treatment with Tramadol Almus and monoamine oxidase inhibitors (a type of medicine used to treat depression) should be avoided.
Both the effect and duration of pain relief produced by Tramadol Almus may be reduced if you take medicines that contain:
Your doctor will tell you whether you should take this medicine and in what dose.
The risk of side effects increases
Concomitant use of Tramadol Almus with sedatives or medicines for the treatment of insomnia (such as benzodiazepines) or gabapentin or pregabalin for the treatment of epilepsy or pain due to nerve problems (neuropathic pain) increases the risk of drowsiness, respiratory difficulties (respiratory depression), coma, or may be potentially fatal. Due to this, concomitant use should only be considered when no other treatment options are possible. However, if your doctor prescribes tramadol with sedative medicines, they will limit the dose and duration of concomitant treatment.
Tell your doctor about all sedative medicines you are taking and follow your doctor's dose recommendation strictly. It may be helpful to inform your friends and family about the signs and symptoms indicated above. Contact your doctor if you experience any of these symptoms;
Taking Tramadol Almus with food, drinks, and alcohol
Do not consume alcohol during treatment with this medicine, as its effects may be intensified.
Food does not affect the effect of Tramadol.
Children and adolescents
Use in children with respiratory problems.
Tramadol is not recommended for use in children with respiratory problems, as the symptoms of tramadol toxicity may worsen in these children.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
There is very little information available on the safety of tramadol in pregnant women. Therefore, you should not take this medicine if you are pregnant.
Chronic treatment during pregnancy may cause withdrawal syndrome in newborns.
Tramadol is excreted in breast milk. For this reason, you should not take this medicine more than once during breastfeeding, or if you take Tramadol Almus more than once, you should interrupt breastfeeding.
Based on human experience, it is not suggested that tramadol affects fertility in men and women.
Driving and using machines
Ask your doctor whether you can drive or use machines while taking this medicine. It is important that before driving or using machines, you observe how this medicine affects you. Do not drive or use machines if you feel drowsy, dizzy, have blurred vision or double vision, or have difficulty concentrating. Be particularly careful at the start of treatment, after a dose increase, after a change in formulation, and/or when administering it concomitantly with other medicines.
This medicine contains less than 1 mmol of sodium (23 mg) per 50 mg of tramadol hydrochloride; it is essentially "sodium-free".
Follow exactly the administration instructions of this medicine given by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
Before starting treatment and regularly during treatment, your doctor will also explain what you can expect from the use of this medicine, when and for how long you should use it, when you should contact your doctor, and when you should stop using it (see also section 2).
The dose should be adjusted according to the intensity of the pain and your individual sensitivity to pain. Normally, you should take the lowest dose that relieves the pain. Do not take more than 400 mg of tramadol hydrochloride per day, unless your doctor has told you to do so.
Unless your doctor has given you different instructions, the recommended dose is:
Adults and adolescents over 12 years
Normally, the initial dose is 1-2 capsules (equivalent to 50-100 mg of tramadol hydrochloride).
Depending on the pain, the effect may last between 4-6 hours.
Children
This medicine is not recommended for children under 12 years of age.
Elderly patients
In elderly patients (over 75 years), the elimination of tramadol may be slow. If this is the case, your doctor may recommend prolonging the dosing intervals.
Patient with liver or kidney impairment/patients on dialysis
If you have severe liver or kidney disease, treatment with this medicine is not recommended. If you have moderate liver or kidney impairment, your doctor may prolong the dosing intervals.
How and when should I take Tramadol?
Tramadol capsules are for oral use.
The capsules should be swallowed whole, without dividing or chewing them, and with sufficient liquid. The capsules can be taken with or without food.
How long should I take Tramadol?
This medicine should not be taken for longer than strictly necessary. If you require prolonged treatment, your doctor will monitor you at short and regular intervals (if necessary with interruptions in treatment) to see if you should continue treatment with this medicine and at what dose.
If you think the effect of this medicine is too strong or too weak, tell your doctor or pharmacist.
If you take more Tramadol Almus than you should
If you have taken an extra dose by mistake, it will generally not have negative effects. You should take the next dose as prescribed.
After taking very high doses of tramadol, you may experience constricted pupils, vomiting, decreased blood pressure, increased heart rate, collapse, decreased level of consciousness up to coma (deep unconsciousness), seizures, and difficulty breathing that can lead to respiratory arrest. In this case, call a doctor immediately!
In case of overdose or accidental ingestion, consult your doctor, pharmacist, or call the Toxicology Information Service, telephone 91 562 04 20, indicating the medicine and the amount taken. It is recommended to take the medicine leaflet to the healthcare professional.
If you forget to take Tramadol Almus
If you forget to take this medicine, it is likely that the pain will return. Do not take a double dose to make up for forgotten doses; simply continue taking Tramadol Almus as you have been doing until now.
If you stop taking Tramadol Almus
If you stop or finish treatment with this medicine too soon, it is likely that the pain will return. If you want to stop treatment due to side effects, consult your doctor.
Do not stop taking this medicine suddenly unless your doctor tells you to do so. If you want to stop taking your medicine, talk to your doctor first, especially if you have been taking it for a long time. Your doctor will tell you when and how to stop it, which can be done by gradually reducing the dose to reduce the likelihood of unnecessary side effects (withdrawal symptoms).
Generally, no side effects are experienced when treatment with tramadol is stopped. However, in rare cases, people who have been taking Tramadol Almus for some time may feel unwell if they stop treatment abruptly. They may feel agitated, anxious, nervous, or trembly. They may be overactive, have difficulty sleeping, or have digestion and bowel problems. Very few people may have panic attacks, hallucinations, unusual perceptions such as itching, tingling, and numbness, and ringing in the ears (tinnitus). Very rarely, unusual symptoms of the central nervous system have been detected, such as confusion, delirium, change in perception of personality (depersonalization), and change in perception of reality (derealization) and persecution delusions (paranoia). If you experience any of these symptoms after stopping treatment with this medicine, consult your doctor.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.
You should consult your doctor immediately if you experience symptoms of an allergic reaction such as swelling of the face, tongue, and/or throat and/or difficulty swallowing and rash along with difficulty breathing.
The most frequent adverse effects during treatment with tramadol are nausea and dizziness, which occur in more than 1 in 10 people.
Very Common: may affect more than 1 in 10 people
Common: may affect up to 1 in 10 people
Uncommon: may affect up to 1 in 100 people
Rare: may affect up to 1 in 1,000 people
Very Rare: may affect up to 1 in 10,000 people
Frequency Not Known: frequency that cannot be estimated from the available data
Reporting of Adverse Effects
If you experience any type of adverse effect, consult your doctor, pharmacist, or nurse, even if it is a possible adverse effect that is not listed in this prospectus. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of sight and reach of children.
Store this medicine in a safe and protected place, where others cannot access it. This medicine can cause serious harm and even be fatal to people who have not been prescribed it.
Do not use this medicine after the expiration date that appears on the box and blister. The expiration date is the last day of the month indicated.
Keep the capsules in their original packaging.
Medicines should not be thrown away through drains or into the trash. Deposit the packaging and medicines you no longer need at the SIGRE Point in the pharmacy. In case of doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. This way, you will help protect the environment.
Composition of Tramadol Almus
Capsule content: Microcrystalline cellulose, sodium starch glycolate (type A), anhydrous colloidal silica, and magnesium stearate.
Capsule shell: Gelatin and titanium dioxide (E171).
Appearance of Tramadol Almus and Package Contents
Hard gelatin capsules containing white or almost white powder.
Package sizes: 10, 20, 30, 60, and 100 capsules.
Not all package sizes may be marketed.
Marketing Authorization Holder
Almus Farmacéutica, S.A.U.
Marie Curie, 54
08840 Viladecans (Barcelona), Spain
Phone: 93 739 71 80
Email: farmacovigilancia@almusfarmaceutica.es
Manufacturer
Pharmadox Healthcare Limited
Kw20a Kordin Industrial Park, Paola, PLA 3000, Malta
This medicine is authorized in the EEA member states under the following names:
Spain: | Tramadol Almus 50 mg hard capsules EFG |
France: | Tramadol Almus |
Date of the Last Revision of this Prospectus:February 2025
Detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es/).